Since we'll probably agree on prevalence I am curious what part(s) you think are optimistic (Avg cost per patient, % reimbursed, how long it will take to reach 2/3 penetration)?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.